Diaminediols for the treatment of Alzheimer's disease
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to compounds of formula (I):
useful in treating Alzheimer'"'"'s disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer'"'"'s disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful in pharmaceutical compositions and methods of treatment to reduce A beta peptide formation.
50 Citations
7 Claims
-
1. A compound of the formula I:
- View Dependent Claims (2, 3, 4, 5, 6, 7)
-
2. A compound according to claim 1 with the proviso that neither RN nor RN′
- is an alpha amino acid.
-
3. A compound according to claim 2 wherein
R1 is C1– - C10 alkyl optionally substituted with 1, 2, or 3 groups independently selected from halogen, —
OH, ═
O, —
SH, —
C≡
N, —
CF3, —
C1–
C3 alkoxy, —
S—
(C1–
C3)alkyl, amino, mono- or dialkylamino, —
N(R)C(O)R′
—
, —
OC(═
O)-amino and —
OC(═
O)-mono- or dialkylamino, orR1 is C2–
C6 alkenyl or C2–
C6 alkynyl, each of which is optionally substituted with 1, 2, or 3 groups independently selected from halogen, —
OH, —
SH, —
C≡
N, —
CF3, C1–
C3 alkoxy, amino, and mono- or dialkylamino.
- C10 alkyl optionally substituted with 1, 2, or 3 groups independently selected from halogen, —
-
4. A compound according to claim 3 wherein
R1′ - is —
CH2-phenyl where the phenyl ring is optionally substituted with 1, 2, 3, or 4 groups independently selected from halogen, C1–
C4 alkoxy, hydroxy, —
NO2, and C1–
C4 alkyl optionally substituted with 1, 2, or 3 substituents independently selected from halogen, OH, SH, NH2, NH(C1–
C6 alkyl), N—
(C1–
C6 alkyl)(C1–
C6 alkyl), C≡
N, CF3.
- is —
-
5. A compound according to claim 4 wherein
RN and RN′ - are independently —
C(═
O)—
(CRR′
)0-6R100; andR′
100 represents aryl, heteroaryl, heterocyclyl, where the ring portions of each are optionally substituted with 1, 2, or 3 groups independently selected from—
OR, —
NO2, C1–
C6 alkyl, halogen, —
C≡
N, —
OCF3, —
CF3, —
(CH2)0-4—
O—
P(═
O)(OR)(OR′
), —
(CH2)0-4—
CO—
NR105R′
105, —
(CH2)0-4—
O—
(CH2)0-4—
CONR102R102′
, —
(CH2)0-4—
CO—
(C1–
C12 alkyl), —
(CH2)0-4—
CO—
(C2–
C12 alkenyl), —
(CH2)0-4—
CO—
(C2–
C12 alkynyl), —
(CH2)0-4—
CO—
(CH2)0-4(C3–
C7 cycloalkyl), —
(CH2)0-4—
R110, —
(CH2)0-4—
R120, —
(CH2)0-4—
R130, —
(CH2)0-4—
CO—
R110, —
(CH2)0-4—
CO—
R120, —
(CH2)0-4—
CO—
R130, —
(CH2)0-4—
CO—
R140, —
(CH2)0-4—
CO—
O—
R150, —
(CH2)0-4—
SO2—
NR105R′
105, —
(CH2)0-4—
SO—
(C1–
C8 alkyl), —
(CH2)0-4—
SO2-(C1–
C12 alkyl), —
(CH2)0-4—
SO2—
(CH2)0-4—
(C3–
C7 cycloalkyl), —
(CH2)0-4—
N(R150)—
CO—
O—
R150, —
(CH2)0-4—
N(R150)—
CO—
N(R150)2, —
(CH2)0-4—
N(R150)—
CS—
N(R150)2, —
(CH2)0-4—
N(R150)—
CO—
R105, —
(CH2)0-4—
NR105R′
105, —
(CH2)0-4—
R140, —
(CH2)0-4—
O—
CO—
(C1–
C6 alkyl), —
(CH2)0-4—
O—
P(O)—
(O—
R110)2, —
(CH2)0-4—
O—
CO—
N(R150)2, —
(CH2)0-4—
O—
CS—
N(R150)2, —
(CH2)0-4—
O—
(R150), —
(CH2)0-4—
O—
R150′
—
COOH, —
(CH2)0-4—
S—
(R150), —
(CH2)0-4—
N(R150)—
SO2—
R105, —
(CH2)0-4—
C3–
C7 cycloalkyl, (C2–
C10)alkenyl, and (C2–
C10)alkynyl, orR′
100 is C1–
C10 alkyl optionally substituted with 1, 2, or 3 R115 groups.
- are independently —
-
6. A compound according to claim 5 wherein
RN′ - is —
C(═
O)-aryl optionally substituted with 1, 2, or 3 groups independently selected from—
OR, —
NO2, C1–
C6 alkyl, halogen, —
C≡
N, —
OCF3, —
CF3, —
(CH2)0-4—
CO—
NR105R′
105, and —
(CH2)0-4—
N(R150)—
SO2—
R105, orRN′
is —
C(═
O)—
C1–
C10 alkyl optionally substituted with 1, 2, or 3 groups independently selected from halogen, —
OH, —
CO2R102, —
C1–
C6 thioalkoxy, —
CO2-phenyl, —
NR105R′
105, —
SO2—
(C1–
C8 alkyl), —
C(═
O)R180, R180, —
CONR105R′
105, —
SO2NR105R′
105, —
NH—
CO—
(C1–
C6 alkyl), —
NH—
CO—
R110, —
NH—
CO—
R120, —
NH—
C(═
O)—
OH, —
NH—
C(═
O)—
OR, —
NH—
C(═
O)—
O-phenyl, —
O—
C(═
O)—
(C1–
C6 alkyl), —
O—
C(═
O)-amino, —
O—
C(═
O)-mono- or dialkylamino, —
O—
C(═
O)-phenyl, —
O—
(C1–
C6 alkyl)-CO2H, —
NH—
SO2—
(C1–
C6 alkyl), C1–
C6 alkoxy and C1–
C6 haloalkoxy.
- is —
-
7. A compound according to claim 1 selected from the group consisting of:
-
5-(acetylamino)-1,2,5,6-tetradeoxy-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, N-[(1S,2R,3R,4R)-4-(acetylamino)-1-benzyl-2,3-dihydroxyoctyl]-2-[methyl(methylsulfonyl)amino]-1,3-thiazole-4-carboxamide, N-[(1S,2R,3R,4R)-4-(benzoylamino)-1-benzyl-2,3-dihydroxyoctyl]-2-[methyl(methylsulfonyl)amino]-1,3-thiazole-4-carboxamide, 5-(acetylamino)-1,2,5,6-tetradeoxy-7-S-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-7-thio-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-7-S-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-7-thio-D-gluco-heptitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-7-O-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-7-O-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-D-gluco-heptitol, 5-(acetylamino)-6-cyano-1,2,5,6-tetradeoxy-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, 5-(benzoylamino)-6-cyano-1,2,5,6-tetradeoxy-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, N-[(1S,2R,3R,4R)-4-(acetylamino)-1-benzyl-2,3-dihydroxyoctyl]-2-[(methylsulfonyl)amino]-1,3-thiazole-4-carboxamide, N-[(1S,2R,3R,4R)-4-(benzoylamino)-1-benzyl-2,3-dihydroxyoctyl]-2-[(methylsulfonyl)amino]-1,3-thiazole-4-carboxamide, 5-(acetylamino)-1,2,5,6-tetradeoxy-7-S-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-7-thio-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-7-S-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-7-thio-D-gluco-heptitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-7-O-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-7-O-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-D-gluco-heptitol, 5-(acetylamino)-6-cyano-1,2,5,6-tetradeoxy-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, 5-(benzoylamino)-6-cyano-1,2,5,6-tetradeoxy-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, N-[(1S,2R,3R,4R)-4-(acetylamino)-1-benzyl-2,3-dihydroxyoctyl]-2-[methyl(methylsulfonyl)amino]-1,3-oxazole-4-carboxamide, N-[(1S,2R,3R,4R)-4-(benzoylamino)-1-benzyl-2,3-dihydroxyoctyl]-2-[methyl(methylsulfonyl)amino]-1,3-oxazole-4-carboxamide, 5-(acetylamino)-1,2,5,6-tetradeoxy-7-S-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-7-thio-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-7-S-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-7-thio-D-gluco-heptitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-7-O-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-7-O-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-D-gluco-heptitol, 5-(acetylamino)-6-cyano-1,2,5,6-tetradeoxy-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, 5-(benzoylamino)-6-cyano-1,2,5,6-tetradeoxy-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, N-[(1S,2R,3R,4R)-4-(acetylamino)-1-benzyl-2,3-dihydroxyoctyl]-2-[(methylsulfonyl)amino]-1,3-oxazol-4-carboxamide, N-[(1S,2R,3R,4R)-4-(benzoylamino)-1-benzyl-2,3-dihydroxyoctyl]-2-[(methylsulfonyl)amino]-1,3-oxazol-4-carboxamide, 5-(acetylamino)-1,2,5,6-tetradeoxy-7-S-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-7-thio-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-7-S-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-7-thio-D-gluco-heptitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-7-O-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-7-O-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-D-gluco-heptitol, 5-(acetylamino)-6-cyano-1,2,5,6-tetradeoxy-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, 5-(benzoylamino)-6-cyano-1,2,5,6-tetradeoxy-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-1-phenyl-D-glucitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-1-(3,5difluorophenyl)-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-D-glucitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-1-(3,5difluorophenyl)-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-D-glucitol, N-[(1S,2R,3R,4R)-4-(acetylamino)-1-(3,5-difluorobenzyl)-2,3-dihydroxyoctyl]-2-[methyl(methylsulfonyl)amino]-1,3-thiazole-4-carboxamide, N-[(1S,2R,3R,4R)-4-(benzoylamino)-1-(3,5-difluorobenzyl)-2,3-dihydroxyoctyl]-2-[methyl(methylsulfonyl)amino]-1,3-thiazole-4-carboxamide, 5-(acetylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-S-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-7-thio-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-S-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-7-thio-D-gluco-heptitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-O-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-O-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-D-gluco-heptitol, 5-(acetylamino)-6-cyano-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-D-glucitol, 5-(benzoylamino)-6-cyano-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-2-[({2-[methyl(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-D-glucitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-D-glucitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-D-glucitol, N-[(1S,2R,3R,4R)-4-(acetylamino)-1-(3,5-difluorobenzyl)-2,3-dihydroxyoctyl]-2-[(methylsulfonyl)amino]-1,3-thiazole-4-carboxamide, N-[(1S,2R,3R,4R)-4-(benzoylamino)-1-(3,5-difluorobenzyl)-2,3-dihydroxyoctyl]-2-[(methylsulfonyl)amino]-1,3-thiazole-4-carboxamide, 5-(acetylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-S-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-7-thio-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-S-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-7-thio-D-gluco-heptitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-O-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-O-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-D-gluco-heptitol, 5-(acetylamino)-6-cyano-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-D-glucitol, 5-(benzoylamino)-6-cyano-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-2-[({2-[(methylsulfonyl)amino]-1,3-thiazol-4-yl}carbonyl)amino]-D-glucitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-D-glucitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-D-glucitol, N-[(1S,2R,3R,4R)-4-(acetylamino)-1-(3,5-difluorobenzyl)-2,3-dihydroxyoctyl]-2-[methyl(methylsulfonyl)amino]-1,3-oxazole-4-carboxamide, N-[(1S,2R,3R,4R)-4-(benzoylamino)-1-(3,5-difluorobenzyl)-2,3-dihydroxyoctyl]-2-[methyl(methylsulfonyl)amino]-1,3-oxazole-4-carboxamide, 5-(acetylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-S-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-7-thio-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-S-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-7-thio-D-gluco-heptitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-O-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-O-methyl-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-D-gluco-heptitol, 5-(acetylamino)-6-cyano-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-D-glucitol, 5-(benzoylamino)-6-cyano-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-2-[({2-[methyl(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-D-glucitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-D-glucitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-D-glucitol, N-[(1S,2R,3R,4R)-4-(acetylamino)-1-(3,5-difluorobenzyl)-2,3-dihydroxyoctyl]-2-[(methylsulfonyl)amino]-1,3-oxazole-4-carboxamide, N-[(1S,2R,3R,4R)-4-(benzoylamino)-1-(3,5-difluorobenzyl)-2,3-dihydroxyoctyl]-2-[(methylsulfonyl)amino]-1,3-oxazole-4-carboxamide, 5-(acetylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-S-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-7-thio-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-S-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-7-thio-D-gluco-heptitol, 5-(acetylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-O-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-D-gluco-heptitol, 5-(benzoylamino)-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-7-O-methyl-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-D-gluco-heptitol, 5-(acetylamino)-6-cyano-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-D-glucitol, and 5-(benzoylamino)-6-cyano-1,2,5,6-tetradeoxy-1-(3,5-difluorophenyl)-2-[({2-[(methylsulfonyl)amino]-1,3-oxazol-4-yl}carbonyl)amino]-D-glucitol.
-
-
2. A compound according to claim 1 with the proviso that neither RN nor RN′
Specification
- Resources
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneePharmacia & Upjohn LLC (Pfizer Inc.)
-
Original AssigneePharmacia & Upjohn Company (Pfizer Inc.)
-
InventorsChrusciel, Robert A., Schostarez, Heinrich Josef
-
Primary Examiner(s)Saeed, Kamal A.
-
Assistant Examiner(s)Coppins, Janet L
-
Application NumberUS10/192,625Publication NumberTime in Patent Office1,448 DaysField of Search548/190, 548/200, 546/304, 546/314, 564/297, 564/300, 514/615, 514/649, 514/354, 514/423, 514/448, 514/471US Class Current514/354CPC Class CodesA61P 25/28 for treating neurodegenerat...A61P 43/00 Drugs for specific purposes...A61P 9/10 for treating ischaemic or a...C07C 235/84 with the carbon atom of at ...C07C 255/44 at least one of the singly-...C07C 271/20 to carbon atoms of hydrocar...C07C 323/42 Y being a carbon atom of a ...C07D 213/82 in position 3C07D 263/34 with hetero atoms or with c...C07D 263/48 Nitrogen atoms not forming ...C07D 277/56 Carbon atoms having three b...